Consortium on Law and Values in Health, Environment & the Life Sciences

STEM CELL INSTITUTE

Cameron CM, Hu WS, Kaufman DS. Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. Biotechnology and Bioengineering. 2006;94(5):938-948.

Jing, Y, Vaessen, B, Lenvik, T, Blackstad, M. Reyes, M, Verfaillie, CM. Multipotent Progenitor cells can be isolated from post-natal murine bone marrow, muscle and brain. Experimental Hematology. June 2006; 34(6):809.

Narayan AD, Chase JL, Lewis RL, Tian XH, Kaufman DS, Thomson JA, Zanjani ED. Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood. 2006;107(5): 2180-83.

Tolar J, O'Shaughnessy MJ, Panoskaltsis-Mortari A, McElmurry RT, Bell S, Riddle M, McIvor RS, Yant SR, Kay MA, Krause D, Verfaillie CM, Blazar BR. Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells. Blood. 2006;107(10):4182-88.

Maes C, Coenegrachts L, Stockmans I, Daci E, Luttun A, Petryk A, Gopalakrishnan R, Moermans K, Smets N, Verfaillie CM, Carmeliet P, Bouillon R, Carmeliet G. Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. Journal of Clinical Investigation. 2006;116(5):1230-42.

Burns TC, Ortiz-Gonzalez XR, Perez MG, Keene CD, Demorest ZL, Nakagawa Y, Garcia-Verdugo JM, Prosper F, Low WC, Verfaillie CM. BrdU is not a reliable label for transplanted cells in the central nervous system. Experimental Neurology. 2006;198(2):562.

Chu L, Jiang Y, Hao H, Wei Q, Xia, Y, Verfaillie C, Zweier J, Liu Z. Inhibition of nitric oxide synthase does not change oct-4 expression or differentiation of bone marrow stem cells into endothelial cells in vitro. FASEB Journal. 2006;20(5):A1126.

Fine GC, Serafini M, Jiang Y, Oki M, Buckley S, Panoskaltsis-Mortari A, Lien L, Hereman Y, Marker P, Nelson-Holte M, Blazar BR, Verfaillie CM. Multipotent adult progenitor cells can reconstitute lymphohematopoietic lineages and contribute to nonhematopoietic systems in irradiated immunodeficient mice. Journal of Investigative Medicine. 2006;54(1):S153-54.

Kwan TT, Liang R, Verfaillie CM, Ekker SC, Chan LC, Lin S, Leung AYH. Regulation of primitive hematopoiesis in zebrafish embryos by the death receptor gene. Experimental Hematology. 2006;34(1):27-34.

Qiu CH, Hanson E, Olivier E, Inada M, Kaufman DS, Gupta S, Bouhassira EE. Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Experimental Hematology. 2005;33(12):1450-58.

Schwartz RE, Linehan JL, Painschab MS, Hu WS, Verfaillie CM, Kaufman DS. Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem Cells and Development. 2005;14(6):643-55.

Reyes M, Dudek A, B. Jahagirdar, Koodie L, Verfaillie CM. Origin of endothelial progenitors in human post-natal bone marrow. Journal of Clinical Investigation. 2002;109: 337-46.

Liu H, Verfaillie CM. Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the Rhodamin-c-Kit+CD33-CD38- fraction of umbilical cord CD34+ cells. Experimantal Hematology. 2002;30:582-9.

Schwartz, RE, Reyes, M, Koodie, Jiang Y, Blackstad M, Johnson S, Lund T, Lenvik T, Hu W-S, Verfaillie CM. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. Journal of Clinical Investigation. 2002;109, 1291-1302.

Lenvik T, Lund T. Verfaillie CM. Blockerette-ligated catpture T7 amplified RT-PCR a new method for determining flankin sequences. Molecular Therapy. 2002;6:113-8.

Jiang Y, Jahagirdar B, Reinhard L, Schwartz RE, Keene CD, Ortiz X, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Largaespada DA, Verfaillie CM. Pluripotent nature of adult marrow derived mesenchymal stem cells. Nature. 2002;418:41-9.

Lewis ID, Du J, Almeida-Porada J, Zanjani ED, Verfaillie CM. Long-term repopulating cord blood stem cells are preserved after ex-vivo culture in a non-contact system. Blood. 2001;97:3441-9.

Zhao RCH, Jiang Y, Verfaillie CM. A model of human p210/ABL mediated CML by transducing primary normal human CD34+ cells with a BCR/ABL containing retroviral vector. Blood. 2001;97:2406-121.

Reyes M, Lenvik T, Lund T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of post-natal human marrow mesodermal progenitor cells. Blood2001;98: 2615-75.

Gupta P, Dudek A, Slungaard A, Oegema T, Verfaillie CM. 6-0-sulfated heparin enhances IL3+MIP-1a mediated expansion of LTC-IC in stroma-free cultures. Blood. 2000;95:147-55.

Jiang Y, Prosper F, Verfaillie CM. Opposing effects of engagement of integrins and stimulation of cytokine receptors on cell cycle progression of normal human hematopoietic progenitors. Blood. 2000;95:846-54.

Jiang Y, Zhao RCH, Verfaillie CM. Inactivation of the cyclin-dependent kinase inhibitor, p27, is responsible for overriding the integrin-mediated inhibition of CML CD34+ cells. Proceedings of the National Academy of Science United States of America. 2000;97:10538-43.

Verfaillie CM., Almeida-Porada G, Wissink S, Zanjani ED. Short- and long-term engraftment of CD34- and CD34+ cells from mobilized blood differs from that of CD34- and CD34+ cells from bone marrow. Experimental Hematology. 2000;28:1071-9.

Verfaillie CM. Stem cell plasticity. Graft. 2000;3:296-8.